After effectively accepting Mullings by stating that “the weekly blood tests in this case would likely be considered an activity that would be included in the time spent administering therapy” since the “weekly blood tests were required to ensure that the proper Phe level was being maintained,” the Directorate went on to state::
We note that although the blood tests could be considered time spent administering therapy, any travel time to and from a blood test would be specifically excluded as per paragraph 118.3(1.1)(d) of the Act.
Although paragraph 118.3(1.1)(d) of the Act specifically excludes time spent on activities related to medical appointments, it is our view that an appointment where therapy is actually received would not fall under this exclusion.